EMC Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34K | Sell |
700
-800
| -53% | -$38.9K | 0.02% | 275 |
|
|
2025
Q1 | $51K | Sell |
1,500
-2,000
| -57% | -$68K | 0.03% | 255 |
|
|
2024
Q4 | $138K | Buy |
3,500
+170
| +5% | +$6.7K | 0.08% | 201 |
|
|
2024
Q3 | $216K | Sell |
3,330
-5,970
| -64% | -$387K | 0.14% | 148 |
|
|
2024
Q2 | $496K | Buy |
9,300
+8,300
| +830% | +$443K | 0.29% | 38 |
|
|
2024
Q1 | $66K | Buy |
+1,000
| New | +$66K | 0.04% | 258 |
|